PHARMACOKINETICS, IMMUNOGENICITY, AND EXPOSURE–RESPONSE RELATIONSHIPS OF USTEKINUMAB TREATMENT IN PATIENTS WITH CROHN’S DISEASE: RESULTS FROM THE WEEK 48 TREAT TO TARGET VS STANDARD OF CARE ANALYSIS OF THE STARDUST STUDY

Silvio Danese  ¹     Severine Vermeire  ²     Geert R. D'Haens  ³     Omoniyi J. Adedokun  ⁴     Julian Panés  ⁵     Axel Dignass  ⁶     Fernando Magro  ⁷     Maciej Nazar     Marjolein Lahaye     Manuela Le Bars     Lioudmila Ni     Daniel R. Gaya     Ivana Bravata     Laurent Peyrin-Biroulet    
¹ Humanitas University,Milan,Italy
² University Hospitals Leuven,Leuven,Belgium
³ University of Amsterdam,Amsterdam,Netherlands
⁴ Janssen Research & Development,Pennsylvania,United States
⁵ Hospital Clinic of Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
⁶ Agaplesion Markus Hospital,Frankfurt/Main,Germany
⁷ Institute for Molecular and Cel

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)